A new artificial intelligence model developed by USC researchers and published in Nature Methods can predict how different proteins may bind to DNA with accuracy across different types of protein, a technological advance that promises to reduce the time required to develop new drugs and other medical treatments.
FDA approves AstraZeneca, Ionis’ ATTR drug as showdown with Alnylam heats up
The FDA on Thursday approved Ionis and AstraZeneca’s treatment for a fatal neurodegenerative disease as the pair joins a space long dominated by Alnylam’s siRNA medicines.
December 22, 2023